U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
80.23
+2.02 (2.58%)
Aug 19, 2026, 1:08 PM EDT - Market open

U.S. Physical Therapy Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
668.89642.78553.64508.38459.04433.03
Other Revenue
135.39130.56110.7990.2588.5556.69
804.27773.34664.43598.63547.6489.72
Revenue Growth
11.36%16.39%10.99%9.32%11.82%17.06%
Cost of Revenue
631.62602.32518.3461.99421.56372.54
Gross Profit
172.65171.02146.13136.64126.04117.18
Selling, General & Admin
71.9969.2658.2951.9546.1146.53
Operating Expenses
93.0590.3276.1466.9160.0546.53
Operating Income
79.6180.769.9969.7365.9970.65
Interest Expense
-10.76-9.46-8.02-9.3-5.78-0.94
Interest & Investment Income
0.10.113.943.77--
Earnings From Equity Investments
1.461.481.010.961.180.11
Other Non Operating Income (Expenses)
0.26-0.860.282.970.851.42
EBT Excluding Unusual Items
70.6671.9667.268.1362.2471.23
Merger & Restructuring Charges
-0.22-0.27-4.36-0.18-0.07-
Impairment of Goodwill
----17.5-9.11-
Gain (Loss) on Sale of Investments
--0.12----
Gain (Loss) on Sale of Assets
---2.42---
Legal Settlements
------2.64
Other Unusual Items
-2.996.24-0.22-1.082.524.6
Pretax Income
67.4577.8160.2149.3855.5773.2
Income Tax Expense
17.5819.8114.6112.1612.1615.27
Earnings From Continuing Operations
49.8758.0145.637.2243.4157.92
Minority Interest in Earnings
-17.64-18.42-14.18-8.98-11.25-17.09
Net Income
32.2339.5831.4228.2432.1640.83
Preferred Dividends & Other Adjustments
29.5718.013.710.12.99.69
Net Income to Common
2.6621.5727.7318.1429.2631.14
Net Income Growth
-92.31%-22.20%52.86%-38.01%-6.04%-1.99%
Shares Outstanding (Basic)
151515141313
Shares Outstanding (Diluted)
151515141313
Shares Change
0.18%0.74%6.17%9.26%0.68%0.49%
EPS (Basic)
0.181.421.841.282.252.41
EPS (Diluted)
0.181.421.841.282.252.41
EPS Growth
-92.32%-22.77%43.97%-43.27%-6.49%-2.66%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
64.0760.9965.7572.6850.2968.21
Free Cash Flow Per Share
4.234.024.375.123.875.29
Dividend Per Share
1.8201.8001.7601.7201.6401.460
Dividend Growth
2.25%2.27%2.33%4.88%12.33%356.25%
Gross Margin
21.47%22.12%21.99%22.83%23.02%23.93%
Operating Margin
9.90%10.44%10.53%11.65%12.05%14.43%
Profit Margin
0.33%2.79%4.17%3.03%5.34%6.36%
Free Cash Flow Margin
7.97%7.89%9.90%12.14%9.18%13.93%
EBITDA
102.01103.0988.6785.4380.7382.24
EBITDA Margin
12.68%13.33%13.35%14.27%14.74%16.79%
D&A For EBITDA
22.422.3918.6815.714.7411.59
EBIT
79.6180.769.9969.7365.9970.65
EBIT Margin
9.90%10.44%10.53%11.65%12.05%14.43%
Effective Tax Rate
26.06%25.46%24.26%24.62%21.89%20.87%
Revenue as Reported
812.2780.99671.35604.8553.14495.02
SEC Filings: 10-K · 10-Q